217 related articles for article (PubMed ID: 37355540)
1. Assessing Lung Inflammation and Pathology in Preclinical Models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Wang H; Bozinovski S
Methods Mol Biol; 2023; 2691():97-109. PubMed ID: 37355540
[TBL] [Abstract][Full Text] [Related]
2. Protocols to Evaluate Cigarette Smoke-Induced Lung Inflammation and Pathology in Mice.
Vlahos R; Bozinovski S
Methods Mol Biol; 2018; 1725():53-63. PubMed ID: 29322408
[TBL] [Abstract][Full Text] [Related]
3. Preclinical murine models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Bozinovski S
Eur J Pharmacol; 2015 Jul; 759():265-71. PubMed ID: 25818750
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).
Hansen MJ; Gualano RC; Bozinovski S; Vlahos R; Anderson GP
Pharmacol Ther; 2006 Jan; 109(1-2):162-72. PubMed ID: 16154635
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in pre-clinical mouse models of COPD.
Vlahos R; Bozinovski S
Clin Sci (Lond); 2014 Feb; 126(4):253-65. PubMed ID: 24144354
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis.
Vij N; Chandramani-Shivalingappa P; Van Westphal C; Hole R; Bodas M
Am J Physiol Cell Physiol; 2018 Jan; 314(1):C73-C87. PubMed ID: 27413169
[TBL] [Abstract][Full Text] [Related]
7. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.
Chan SMH; Selemidis S; Bozinovski S; Vlahos R
Pharmacol Ther; 2019 Jun; 198():160-188. PubMed ID: 30822464
[TBL] [Abstract][Full Text] [Related]
8. Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention.
Stockley RA
Curr Med Res Opin; 2009 May; 25(5):1235-45. PubMed ID: 19335322
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation.
Guo-Parke H; Linden D; Weldon S; Kidney JC; Taggart CC
Front Immunol; 2020; 11():1205. PubMed ID: 32655557
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice.
Heulens N; Korf H; Cielen N; De Smidt E; Maes K; Gysemans C; Verbeken E; Gayan-Ramirez G; Mathieu C; Janssens W
Respir Res; 2015 Sep; 16(1):110. PubMed ID: 26376849
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoke exposure as a model of inflammation associated with COPD.
Eltom S; Stevenson C; Birrell MA
Curr Protoc Pharmacol; 2013 Mar; Chapter 5():Unit5.64. PubMed ID: 23456614
[TBL] [Abstract][Full Text] [Related]
12. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
13. Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure.
Gosker HR; Langen RC; Bracke KR; Joos GF; Brusselle GG; Steele C; Ward KA; Wouters EF; Schols AM
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):710-6. PubMed ID: 18988919
[TBL] [Abstract][Full Text] [Related]
14. Animal models of chronic obstructive pulmonary disease.
Fricker M; Deane A; Hansbro PM
Expert Opin Drug Discov; 2014 Jun; 9(6):629-45. PubMed ID: 24754714
[TBL] [Abstract][Full Text] [Related]
15. Increased exploration and hyperlocomotion in a cigarette smoke and LPS-induced murine model of COPD: linking pulmonary and systemic inflammation with the brain.
Pelgrim CE; Wang L; Peralta Marzal LN; Korver S; van Ark I; Leusink-Muis T; Braber S; Folkerts G; Garssen J; van Helvoort A; Kraneveld AD
Am J Physiol Lung Cell Mol Physiol; 2022 Sep; 323(3):L251-L265. PubMed ID: 35699308
[TBL] [Abstract][Full Text] [Related]
16. Mortality in COPD: Role of comorbidities.
Sin DD; Anthonisen NR; Soriano JB; Agusti AG
Eur Respir J; 2006 Dec; 28(6):1245-57. PubMed ID: 17138679
[TBL] [Abstract][Full Text] [Related]
17. Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities.
Bernardo I; Bozinovski S; Vlahos R
Pharmacol Ther; 2015 Nov; 155():60-79. PubMed ID: 26297673
[TBL] [Abstract][Full Text] [Related]
18. COPD and the response of the lung to tobacco smoke exposure.
Taylor JD
Pulm Pharmacol Ther; 2010 Oct; 23(5):376-83. PubMed ID: 20382250
[TBL] [Abstract][Full Text] [Related]
19. Modelling COPD in mice.
Vlahos R; Bozinovski S; Gualano RC; Ernst M; Anderson GP
Pulm Pharmacol Ther; 2006; 19(1):12-7. PubMed ID: 16286233
[TBL] [Abstract][Full Text] [Related]
20. Cigarette Smoke Triggers IL-33-associated Inflammation in a Model of Late-Stage Chronic Obstructive Pulmonary Disease.
Lee JH; Hailey KL; Vitorino SA; Jennings PA; Bigby TD; Breen EC
Am J Respir Cell Mol Biol; 2019 Nov; 61(5):567-574. PubMed ID: 30973786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
